KG

Krupa Gowri Alagiamanavalan

Active Director Director DIN 09537726
DIN 09537726 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Krupa Gowri Alagiamanavalan

Data last updated:

Krupa Gowri Alagiamanavalan is a Director at Gnanika Techbio Private Limited (since 2022). The company operates in Healthcare.

DIN 09537726
Primary Designation Director
Industry Healthcare
First Appointment 16 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gnanika Techbio Private Limited U85100TN2022PTC150584
Director16 Mar 20222022Active

Board colleagues of Krupa Gowri Alagiamanavalan

NameDINCompanyDesignation
Gnanasekaran Gopalsamy09537725Gnanika Techbio Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gnanika Techbio Private Limited
Premium access

Shareholding and investment profile for Krupa Gowri Alagiamanavalan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krupa Gowri Alagiamanavalan

Krupa Gowri Alagiamanavalan currently holds 1 directorship: Gnanika Techbio Private Limited (Director, since 16 Mar 2022).

Krupa Gowri Alagiamanavalan was first appointed on 16 Mar 2022 as Director at Gnanika Techbio Private Limited.

The current boards of Krupa Gowri Alagiamanavalan's companies include Gnanasekaran Gopalsamy (Gnanika Techbio Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available